{"_id":"6ypjPaXgJnJGNo5Db","bibbaseid":"anonymous-drugdiscoverystrategiesandthepreclinicaldevelopmentofdaminoacidoxidaseinhibitorsasantipsychotictherapiesexpertopinionondrugdiscoveryvol13no10","authorIDs":[],"bibdata":{"bibtype":"misc","type":"misc","title":"Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies: Expert Opinion on Drug Discovery: Vol 13, No 10","url":"https://www.tandfonline.com/doi/abs/10.1080/17460441.2018.1524459","urldate":"2020-08-18","bibtex":"@misc{noauthor_drug_nodate,\n\ttitle = {Drug discovery strategies and the preclinical development of {D}-amino-acid oxidase inhibitors as antipsychotic therapies: {Expert} {Opinion} on {Drug} {Discovery}: {Vol} 13, {No} 10},\n\turl = {https://www.tandfonline.com/doi/abs/10.1080/17460441.2018.1524459},\n\turldate = {2020-08-18},\n}\n\n\n\n","key":"noauthor_drug_nodate-1","id":"noauthor_drug_nodate-1","bibbaseid":"anonymous-drugdiscoverystrategiesandthepreclinicaldevelopmentofdaminoacidoxidaseinhibitorsasantipsychotictherapiesexpertopinionondrugdiscoveryvol13no10","role":"","urls":{"Paper":"https://www.tandfonline.com/doi/abs/10.1080/17460441.2018.1524459"},"metadata":{"authorlinks":{}},"downloads":0},"bibtype":"misc","biburl":"https://bibbase.org/zotero/saracatanese","creationDate":"2020-08-23T16:05:52.360Z","downloads":0,"keywords":[],"search_terms":["drug","discovery","strategies","preclinical","development","amino","acid","oxidase","inhibitors","antipsychotic","therapies","expert","opinion","drug","discovery","vol"],"title":"Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies: Expert Opinion on Drug Discovery: Vol 13, No 10","year":null,"dataSources":["6YmXZLKttYg4PnAp9","eTsH756eicg6vxuG3","itYja8xZ34LEKoM25","TZeKmKj6mKcyHY3tK","bPrFNBfwTmrEMKtFc"]}